Andrea Granados-Juárez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Granados-Juárez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Arturo Avendaño-Estrada
División de Investigación, Facultad de Medicina, Unidad Radiofarmacia-Ciclotrón, Universidad Nacional Autónoma de México, Ciudad de México, México
1 shared publication - Eleazar Ramírez Hernández
Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de Mexico, Ciudad de Mexico 04510, Mexico
1 shared publication - Gerardo Bernabé Ramírez-Rodríguez
Laboratorio de Neurogénesis, Dirección y Subdirección de Investigación Biomédica en Salud Mental, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City 14370, Mexico
1 shared publication - Hilda Martínez-Coria
Laboratorio de Neurobiología del Envejecimiento, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico
1 shared publication - Marco Antonio Meraz-Ríos
Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Avenida Instituto Politécnico Nacional 2508, Ciudad de México 07360, Mexico
1 shared publication - Marquiza Sablón-Carrazana
Centro de Neurociencias de Cuba, La Habana 11600, Cuba
1 shared publication
Latest Publications
- Open Access
Animal Models of Alzheimer’s Disease Evaluated with [11C]Pittsburg Compound B
Several animal models of Alzheimer’s disease have been developed and tested for diagnostic and treatment purposes. [11C]PIB is the gold-standard radiotracer for the detection of Aβ plaque deposits, a hallmark of the disease. This study aimed to evaluate the in vivo detection of Aβ plaques using [11C]PIB microPET imaging across different animal models of Alzheimer’s disease. The study included 3xTg-AD transgenic mice, TgF344-AD transgenic rats and Aβ injection-based rat model. The results showed an age-related increase in [11C]PIB uptake in 3xTg-AD mice, particularly in the midbrain and thalamus. In TgF344-AD rats, differences were also observed compared to WT controls, with the highest values observed in the hippocampus and cortex. In the injection-based model, inoculated rats showed greater uptake in the injection site than SHAM animals. Across all microPET studies, [11C]PIB uptake was consistently higher in females than in their male counterparts. These findings support the value of transgenic and Aβ injection-based models in preclinical research on Aβ plaque deposition and highlight the importance of considering species, model type, sex, and age in experimental design.
Open AccessAnimal Models of Alzheimer’s Disease Evaluated with [11C]Pittsburg Compound B
Several animal models of Alzheimer’s disease have been developed and tested for diagnostic and treatment purposes. [11C]PIB is the gold-standard radiotracer for the detection of Aβ plaque deposits, a hallmark of the disease. This study aimed to evaluate the in vivo detection of Aβ plaques using [11C]PIB microPET imaging across different animal models of Alzheimer’s disease. The study included 3xTg-AD transgenic mice, TgF344-AD transgenic rats and Aβ injection-based rat model. The results showed an age-related increase in [11C]PIB uptake in 3xTg-AD mice, particularly in the midbrain and thalamus. In TgF344-AD rats, differences were also observed compared to WT controls, with the highest values observed in the hippocampus and cortex. In the injection-based model, inoculated rats showed greater uptake in the injection site than SHAM animals. Across all microPET studies, [11C]PIB uptake was consistently higher in females than in their male counterparts. These findings support the value of transgenic and Aβ injection-based models in preclinical research on Aβ plaque deposition and highlight the importance of considering species, model type, sex, and age in experimental design.